Frei D, Binswanger U, Fehr J, Briner J, Sauter C, Largiadèr F
Blut. 1980 May;40(5):343-8. doi: 10.1007/BF01025589.
Four cases of acute myelogenous leukemia and six cases of chronic myelogenous leukemia after treatment with azathioprine and prednisone for renal allotransplantation have been described in the literature. We report another two cases of acute leukemia 10 and 5 years after successful renal allotransplantation. Patient 1, a 29-year-old farmer, exhibited the signs of acute lymphatic leukemia resistent to treatment with cytostatic agens. Death was due to pneumonia. Patient 2, a 47-year-old salesman, developed pancytopenia together with splenomegaly. After splenectomy an atypical subacute myeloid leukemia became apparent which was not treated due to withdrawal of the patient. He died 2 months after diagnosis. Both patients received long-term immunosuppressive therapy with azathiopine and prednisone until the leukemia was diagnosed. A relationship between long-term immunosuppression and the occurrence of leukemia is postulated.
文献中已描述了4例肾同种异体移植术后使用硫唑嘌呤和泼尼松治疗后发生急性髓性白血病的病例,以及6例慢性髓性白血病的病例。我们报告另外2例在肾同种异体移植成功后10年和5年发生急性白血病的病例。病例1为一名29岁的农民,表现出对细胞抑制剂治疗耐药的急性淋巴细胞白血病症状。死于肺炎。病例2为一名47岁的推销员,出现全血细胞减少并伴有脾肿大。脾切除术后,出现了非典型亚急性髓性白血病,但由于患者退出治疗而未进行治疗。他在诊断后2个月死亡。两名患者在白血病确诊前均接受了硫唑嘌呤和泼尼松的长期免疫抑制治疗。推测长期免疫抑制与白血病的发生之间存在关联。